Delcath Systems Inc Revenue Growth Rates (DCTH), Current and Historic Growth - CSIMarket
CSIMarket
 


Delcath Systems Inc   (NASDAQ: DCTH)
 

DCTH's Revenue Growth by Quarter and Year

Delcath Systems Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DCTH/growth
https://api.csimarket.com/api/v1/companies/DCTH/fundamentals
https://api.csimarket.com/api/v1/companies/DCTH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
DCTH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 35.10
2nd Quarter June 29.13
1st Quarter March 24.26
FY 88.49

DCTHs Annual Revenue
Delcath Systems Inc 's Revenue in the fiscal year 2025 $ 84.43 millions
Delcath Systems Inc 's Revenue in the fiscal year 2024 $ 37.02 millions
Delcath Systems Inc 's Revenue in the fiscal year 2023 $ 2.07 millions
Delcath Systems Inc 's Revenue in the fiscal year 2022 $ 2.72 millions
Delcath Systems Inc 's Revenue in the fiscal year 2021 $ 3.56 millions




DCTH Revenue third quarter 2026 Y/Y Growth Comment
Delcath Systems Inc reported Revenue surge of 76.04% year on year in the third quarter 2026, to $ 35.10 millions, this is lower than Delcath Systems Inc 's recent average Revenue surge of 171.6%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 60 other companies have achieved higher Revenue growth. While Delcath Systems Inc ' s Revenue jump of 76.04% ranks overall at the positon no. 1012 in the third quarter 2026.




DCTH Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 76.04 %
2nd Quarter June 20.57 %
1st Quarter March 28.09 %
FY   -

Financial Statements
Delcath Systems Inc 's third quarter 2026 Revenue $ 35.10 millions DCTH's Income Statement
Delcath Systems Inc 's third quarter 2025 Revenue $ 19.94 millions Quarterly DCTH's Income Statement


DCTH Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 20.5 %
2nd Quarter June 20.07 %
1st Quarter March 17.03 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #202
Overall #1012

Revenue Y/Y Growth Statistics
High Average Low
2785.34 % 171.6 % -100 %
(Dec 31 2024)   (Dec 31 2019)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #202
Overall #1012
Revenue Y/Y Growth Statistics
High Average Low
2785.34 % 171.6 % -100 %
(Dec 31 2024)   (Dec 31 2019)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Delcath Systems Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
482.37 % 35.57 % -100 %
(Mar 31 2024)  


DCTH's III. Quarter Q/Q Revenue Comment
Delcath Systems Inc achieved in the III. Quarter 2026 below company average Revenue jump of 20.5% quarter on quarter, to $ 35.10 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -17.47% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Delcath Systems Inc 's Revenue growth quarter on quarter, overall rank is 512.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #98
Overall #512
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #98
Overall #512
Revenue Q/Q Growth Statistics
High Average Low
482.37 % 35.57 % -100 %
(Mar 31 2024)  


DCTH's III. Quarter Q/Q Revenue Comment
Delcath Systems Inc achieved in the III. Quarter 2026 below company average Revenue jump of 20.5% quarter on quarter, to $ 35.10 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -17.47% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Delcath Systems Inc 's Revenue growth quarter on quarter, overall rank is 512.


Delcath Systems Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 94.06
Y / Y Revenue Growth (TTM) 35.91 %
Year on Year Revenue Growth Overall Ranking # 46
Seqeuential Revenue Change (TTM) 5.59 %
Seq. Revenue Growth (TTM) Overall Ranking # 544


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Delcath Systems Inc 's cumulative twelve months Revenue were $ 94 millions, company would post below average annual Revenue growth of 5.59% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Delcath Systems Inc 's Revenue growth from the 29.13% growth in Mar 31 2026.

Among companies within the Healthcare sector 10 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 16 to 46.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 11
Overall # 46

Revenue TTM Y/Y Growth Statistics
High Average Low
1692.59 %
116.66 %
-53.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 125
S&P 500 # 544
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Delcath Systems Inc 's cumulative twelve months Revenue were $ 94 millions, company would post below average annual Revenue growth of -53.62% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Delcath Systems Inc 's Revenue growth from the 29.13% growth in Mar 31 2026.

Among companies within the Healthcare sector 10 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 16 to 46.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 11
Overall # 46

Revenue TTM Y/Y Growth Statistics
High Average Low
1692.59 %
116.66 %
-53.62 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 125
S&P 500 # 544




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DCTH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Sonida Senior Living Inc 114.40%$ 114.402 millions
Verastem Inc 113.59%$ 113.592 millions
Hyperfine Inc 109.27%$ 109.270 millions
Pelthos Therapeutics Inc 107.87%$ 107.872 millions
Co diagnostics Inc 94.58%$ 94.580 millions
Autolus Therapeutics Plc94.57%$ 94.574 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________93.02%$ 93.022 millions
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions


About Delcath Systems Inc Revenue Growth Rates (DCTH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Delcath Systems Inc (CIK 872912).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-071915
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Delcath Systems Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.